Obesity natural history, complications and prognosis

Jump to navigation Jump to search

Obesity Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Obesity from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Lifestyle Intervention and Counseling (Comprehensive Lifestyle Intervention)

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

USPSTF Recommendations and Guidelines on Management of Obesity

2017 Guidelines for Screening of Obesity in Children and Adolescents

2012 Guidelines for Screening of Obesity in Adults

AHA/ACC/TOS Guidelines on Management of Overweight and Obesity

2013 AHA/ACC/TOS Guidelines on Management of Overweight and Obesity

Obesity natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Obesity natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Obesity natural history, complications and prognosis

CDC on Obesity natural history, complications and prognosis

Obesity natural history, complications and prognosis in the news

Blogs on Obesity natural history, complications and prognosis

Directions to Hospitals Treating Obesity

Risk calculators and risk factors for Obesity natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Natural History, Complications and Prognosis

Complications

Health consequences can be categorized by the effects of increased fat mass (osteoarthritis, obstructive sleep apnea, social stigmatization) or by the increased number of fat cells (diabetes, cancer, cardiovascular disease, non-alcoholic fatty liver disease).[1][2] Increases in body fat alter the body's response to insulin, potentially leading to insulin resistance. Increased fat also creates a proinflammatory state, increasing the risk of thrombosis.[2]

Medical field Condition Medical field Condition
Cardiology Dermatology
Endocrinology and Reproductive medicine Gastrointestinal
Neurology Oncology[13]
Psychiatry Respirology
Rheumatology and Orthopedics Urology and Nephrology

Prognosis

References

  1. 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 1.14 1.15 1.16 1.17 1.18 1.19 1.20 Haslam DW, James WP (2005). "Obesity". Lancet. 366 (9492): 1197–209. doi:10.1016/S0140-6736(05)67483-1. PMID 16198769.
  2. 2.0 2.1 Bray GA (2004). "Medical consequences of obesity". J. Clin. Endocrinol. Metab. 89 (6): 2583–9. doi:10.1210/jc.2004-0535. PMID 15181027.
  3. Darvall KA, Sam RC, Silverman SH, Bradbury AW, Adam DJ (2007). "Obesity and thrombosis". Eur J Vasc Endovasc Surg. 33 (2): 223–33. doi:10.1016/j.ejvs.2006.10.006. PMID 17185009. Unknown parameter |month= ignored (help)
  4. 4.0 4.1 4.2 4.3 4.4 Yosipovitch G, DeVore A, Dawn A (2007). "Obesity and the skin: skin physiology and skin manifestations of obesity". J. Am. Acad. Dermatol. 56 (6): 901–16, quiz 917–20. doi:10.1016/j.jaad.2006.12.004. PMID 17504714. Unknown parameter |month= ignored (help)
  5. Hahler B (2006). "An overview of dermatological conditions commonly associated with the obese patient". Ostomy Wound Manage. 52 (6): 34–6, 38, 40 passim. PMID 16799182. Unknown parameter |month= ignored (help)
  6. 6.0 6.1 6.2 Arendas K, Qiu Q, Gruslin A (2008). "Obesity in pregnancy: pre-conceptional to postpartum consequences". J Obstet Gynaecol Can. 30 (6): 477–88. PMID 18611299. Unknown parameter |month= ignored (help)
  7. Anand G, Katz PO (2008). "Gastroesophageal reflux disease and obesity". Rev Gastroenterol Disord. 8 (4): 233–9. PMID 19107097.
  8. Harney D, Patijn J (2007). "Meralgia paresthetica: diagnosis and management strategies". Pain Med. 8 (8): 669–77. doi:10.1111/j.1526-4637.2006.00227.x. PMID 18028045.
  9. Bigal ME, Lipton RB (2008). "Obesity and chronic daily headache". Curr Pain Headache Rep. 12 (1): 56–61. doi:10.1007/s11916-008-0011-8. PMID 18417025. Unknown parameter |month= ignored (help)
  10. Sharifi-Mollayousefi A, Yazdchi-Marandi M, Ayramlou H; et al. (2008). "Assessment of body mass index and hand anthropometric measurements as independent risk factors for carpal tunnel syndrome". Folia Morphol. (Warsz). 67 (1): 36–42. PMID 18335412. Unknown parameter |month= ignored (help)
  11. Beydoun MA, Beydoun HA, Wang Y (2008). "Obesity and central obesity as risk factors for incident dementia and its subtypes: A systematic review and meta-analysis". Obes Rev. 9 (3): 204–18. doi:10.1111/j.1467-789X.2008.00473.x. PMID 18331422. Unknown parameter |month= ignored (help)
  12. Wall M (2008). "Idiopathic intracranial hypertension (pseudotumor cerebri)". Curr Neurol Neurosci Rep. 8 (2): 87–93. doi:10.1007/s11910-008-0015-0. PMID 18460275. Unknown parameter |month= ignored (help)
  13. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003). "Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults". N. Engl. J. Med. 348 (17): 1625–38. doi:10.1056/NEJMoa021423. PMID 12711737. Unknown parameter |month= ignored (help)
  14. 14.0 14.1 14.2 Poulain M, Doucet M, Major GC; et al. (2006). "The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies". CMAJ. 174 (9): 1293–9. doi:10.1503/cmaj.051299. PMC 1435949. PMID 16636330. Unknown parameter |month= ignored (help)
  15. Adams JP, Murphy PG (2000). "Obesity in anaesthesia and intensive care". Br J Anaesth. 85 (1): 91–108. doi:10.1093/bja/85.1.91. PMID 10927998. Unknown parameter |month= ignored (help)
  16. Choi HK, Atkinson K, Karlson EW, Curhan G (2005). "Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study". Arch. Intern. Med. 165 (7): 742–8. doi:10.1001/archinte.165.7.742. PMID 15824292. Unknown parameter |month= ignored (help)
  17. Tukker A, Visscher T, Picavet H (2008). "Overweight and health problems of the lower extremities: osteoarthritis, pain and disability". Public Health Nutr: 1–10. doi:10.1017/S1368980008002103. PMID 18426630. Unknown parameter |month= ignored (help)
  18. Molenaar EA, Numans ME, van Ameijden EJ, Grobbee DE (2008). "[Considerable comorbidity in overweight adults: results from the Utrecht Health Project]". Ned Tijdschr Geneeskd (in Dutch; Flemish). 152 (45): 2457–63. PMID 19051798. Unknown parameter |month= ignored (help)
  19. Esposito K, Giugliano F, Di Palo C, Giugliano G, Marfella R, D'Andrea F, D'Armiento M, Giugliano D (2004). "Effect of lifestyle changes on erectile dysfunction in obese men: A randomized controlled trial". JAMA. 291 (24): 2978–84. doi:10.1001/jama.291.24.2978. PMID 15213209.
  20. Hunskaar S (2008). "A systematic review of overweight and obesity as risk factors and targets for clinical intervention for urinary incontinence in women". Neurourol. Urodyn. 27 (8): 749–57. doi:10.1002/nau.20635. PMID 18951445.
  21. Ejerblad E, Fored CM, Lindblad P, Fryzek J, McLaughlin JK, Nyrén O (2006). "Obesity and risk for chronic renal failure". J. Am. Soc. Nephrol. 17 (6): 1695–702. doi:10.1681/ASN.2005060638. PMID 16641153.
  22. Makhsida N, Shah J, Yan G, Fisch H, Shabsigh R (2005). "Hypogonadism and metabolic syndrome: Implications for testosterone therapy". J. Urol. 174 (3): 827–34. doi:10.1097/01.ju.0000169490.78443.59. PMID 16093964. Unknown parameter |month= ignored (help)

Template:WH Template:WS